For April, all three benchmarks logged a third consecutive monthly loss. Now, all eyes on Microsoft (MSFT) and Meta Platforms (META) earnings after the close. Tensions regarding Saudi Arabia's ...

But his next priority — tariffs on medicines — would put millions of Floridians who depend on prescription medications in the trade war crossfire. Floridians know what drug shortages feel like.

A San Diego federal judge has ordered prison officials to involuntarily medicate a conspiracy theorist charged with killing his two young children in Mexico in an attempt to restore his competency ...

Tetragon is a Guernsey closed-ended investment company. Its non-voting shares are listed on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., and also traded on the Specialist ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Ditch rider Nate Blevin said on his route he carries a binder with a monthly log sheet for each turnout where water is delivered. In it, he tracks deliveries by writing the order date, volume ...

LONDON, April 30, 2025 /PRNewswire/ -- Tetragon has released its Monthly Factsheet for March 2025. Net Asset Value: $3,191m Fully Diluted NAV per Share: $35.38 Share Price (TFG NA): $14.25 Monthly ...

After all, corporate earnings are strong, the labor market is in good shape, and households have robust balance sheets ... He sees innovations in GLP-1 medications and AI driving sustained ...

A monthly dosing option for VK2735's injectable ... The good news is that the company benefits from a well-capitalized balance sheet, ending 2024 with $903 million in cash and zero debt.

Yes, the erosion of EYLEA’s exclusivity and IP is concerning, and for good reason. However, the company’s financials, recent legal rulings, capital allocation and late-stage pipeline assets ...